Yeungnam University College of Medicine Trials

Yeungnam University College of Medicine	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Kim, Min Chan

NCT05664555: Dose Optimization for Safe and Efficient Fluorescein Angiography (DOSE Study)

Completed

144

RoW

Fluorescein Sodium

Seoul National University Bundang Hospital

Retinal Disease

03/24

PhALLCON, NCT03589326 / 2018-000397-30: A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia

	Data from PhALLCON Study for newly diagnosed Ph+ ALL at SOHO 2020
	Sep 2019 - Sep 2019: Data from PhALLCON Study for newly diagnosed Ph+ ALL at SOHO 2020
	Initiation of new trial in Ph+ ALL
	Jul 2018 - Jul 2018: Initiation of new trial in Ph+ ALL

Active, not recruiting

245

Europe, Canada, Japan, US, RoW

Ponatinib, Iclusig, Imatinib, Gleevec, Vincristine, Dexamethasone, Cytarabine, Methotrexate, Prednisone

Takeda

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)

08/22

07/27

innovaTV 301, NCT04697628 / 2019-001655-39: Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

Active, not recruiting

502

Europe, Canada, Japan, US, RoW

tisotumab vedotin, TIVDAK, topotecan, vinorelbine, gemcitabine, irinotecan, pemetrexed

Seagen Inc., Genmab

Cervical Cancer

07/23

08/25

FLORA-4, NCT04498117 / 2020-002270-26: Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Active, not recruiting

615

Europe, Canada, US, RoW

Oregovomab, MAb-B43.13, Paclitaxel, Taxol, Carboplatin, Paraplatin, Placebo

CanariaBio Inc., Gynecologic Oncology Group, Iqvia Pty Ltd

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma, Fallopian Tube Neoplasms, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Peritoneal Cancer, Peritoneal Carcinoma, Peritoneal Neoplasms

09/25

08/27

NRG-GY019, NCT04095364: Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recruiting

450

Europe, Canada, US, RoW

Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Imaging Technique, Diagnostic Imaging Technique, Image Type, Imaging, Imaging (procedure), imaging procedure, Imaging Procedures, imaging type, IMAGING_METHOD, imaging_type, Medical Imaging, Type of imaging, Letrozole, CGS 20267, Femara, Fempro, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat

NRG Oncology, National Cancer Institute (NCI)

Low Grade Fallopian Tube Serous Adenocarcinoma, Ovarian Low Grade Serous Adenocarcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma, Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8, Stage III Fallopian Tube Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage III Primary Peritoneal Cancer AJCC v8, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Primary Peritoneal Cancer AJCC v8

02/27

02/28

CRESCENDO, NCT06072131: To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

Recruiting

504

Europe, US, RoW

Belinostat Injection, Beleodaq®, Pralatrexate Injection, Folotyn®, CHOP, Cyclophosphamide, Hydroxydaunorubicin (doxorubicin), Oncovin (vincristine), and Prednisone, COP, Cyclophosphamide, Oncovin (vincristine), and Prednisone

Acrotech Biopharma Inc.

Peripheral T Cell Lymphoma

07/30

11/30

NCT04696120: Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF Trial

Not yet recruiting

200

RoW

Apixaban, apixaban 5mg or 2.5mg bid, Placebo, placebo bid

Korea University Guro Hospital, Dt&Sanomedics

Heart Failure, Sinus Rhythm, Cerebrovascular Disease

08/22

02/23

NCT05665023: Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma

Recruiting

RoW

Bevacizumab + modified FOLFIRINOX

Yonsei University

Mucinous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

02/24

02/25

SRF388-201, NCT05359861: Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma

Active, not recruiting

134

US, RoW

SRF388, Atezolizumab, Tecentriq, Bevacizumab, Avastin, Placebo

Coherus Biosciences, Inc.

Hepatocellular Carcinoma

05/25

05/26

NCT04903873: A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

Recruiting

1/2

110

US, RoW

EU101

Eutilex

Solid Tumor, Renal Cell Cancer Metastatic, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Prostate Cancer

09/25

12/25

BOLD-100-001, NCT04421820 / 2022-003079-41: BOLD-100 in Combination with FOLFOX for the Treatment of Advanced Solid Tumours

Recruiting

1/2

220

Europe, Canada, US, RoW

BOLD-100 in combination with FOLFOX Chemotherapy (Dose Expansion), BOLD-100 in combination with FOLFOX Chemotherapy (Dose Escalation)

Bold Therapeutics, Inc., Bold Therapeutics, Inc. (Bold)

Colorectal Cancer, Pancreatic Cancer, Gastric Cancers, Cholangiocarcinoma

06/26

09/26

NCT05113693: Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393

Completed

RoW

CKD-393, CKD-501, D759, H053

Chong Kun Dang Pharmaceutical

Type 2 Diabetes

12/21

NCT05113849: Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine (IN-B009) in Healthy Adults (COVID-19)

Recruiting

RoW

IN-B009 (Low-dose), IN-B009 (High-dose)

HK inno.N Corporation

COVID-19

02/23

EARLY-UNLOAD, NCT04775472: Early Left Atrial Septostomy Versus Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation

Completed

N/A

116

RoW

Early left atrial septostomy within 12 hours after VA-ECMO implantation, Selective left atrial septostomy

Chonnam National University Hospital

Cardiogenic Shock

03/22

10/23

PLOTS, NCT04066699: Percutaneous Localization: Open-label Registry of Thoracic Surgery

Completed

N/A

Percutaneous localization of suspicious lung lesion(s) using electromagnetic navigation and tools., SPiN Thoracic Navigation System™, Veran System

Veran Medical Technologies

Lung Lesion(s) Requiring Evaluation, Pulmonary Metastasis, Pulmonary Nodule, Solitary, Peripheral Lung Lesions

01/23

02/23

VISION, NCT04151615: VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma

Completed

N/A

203

RoW

Boryung Pharmaceutical Co., Ltd

Multiple Myeloma

01/23

NCT04853563: Comparison of PEEP in Acute Decompensated Heart Failure

Recruiting

N/A

120

RoW

PEEP

Asan Medical Center

Heart Decompensation, Mechanical Ventilation Pressure High

07/23

04/24

NCT03763604: Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer

Approved for marketing

N/A

Europe, Canada, RoW

Abemaciclib, LY2835219

Eli Lilly and Company

Metastatic Breast Cancer

NCT05629611: Efficacy and Safety Evaluation of Vi-sealer

Recruiting

N/A

280

RoW

Vi-Sealer, Ligasure, Other AHD

Hyun Park

Benign Gynecologic Neoplasm

12/24

10/25

NCT04322851: B-line by Lung US in Patients With Acute Decompensated Heart Failure

Recruiting

N/A

300

RoW

Lung ultrasound

Asan Medical Center

Heart Failure

03/24

FRAME-AMI3, NCT06227754: OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts

Recruiting

N/A

1500

RoW

Angiography-guided PCI group, Optical coherence tomography-guided PCI group

Chonnam National University Hospital, Samsung Medical Center

ST Elevation Myocardial Infarction, Myocardial Infarction

12/28

12/29

ORIGO, NCT06597175: Evaluating Investigational Medical Device for Breast Tumor Diagnosis Using Diffusion Optical Spectroscopy

Recruiting

N/A

300

RoW

ORIGO

Olive Healthcare

Breast Cancer, Breast Tumor, Mammary Carcinoma, Human

10/24

NCT06537752: A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients

Recruiting

N/A

1052

RoW

Boryung Pharmaceutical Co., Ltd

Breast Cancer

10/26

EARLY-HF, NCT04810806: Timing of Coronary Angiography in NSTE-ACS With ADHF

Terminated

N/A

316

RoW

Immediate coronary angiography within 2 hours after randomization, Delayed coronary angiography after stabilization of heart failure

Chonnam National University Hospital

Heart Failure, Acute Coronary Syndrome

03/24

NCT04968808: Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI)

Recruiting

N/A

676

RoW

Staged in-hospital complete revascularization, Immediate complete revascularization

Chonnam National University Hospital

Myocardial Infarction, Acute, Multi-Vessel Coronary Artery Stenosis, Multi Vessel Coronary Artery Disease

08/24

08/25

NCT05493904: PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment of COMPLEX Lesion (PRECISION-COMPLEX)

Recruiting

N/A

320

RoW

OCT-guided PCI, Angiography-guided PCI, Drug-eluting stent

Chonnam National University Hospital, Abbott Medical Devices

Coronary Artery Disease, Angina Pectoris

08/24

12/26

NCT06049914: Combined Exercise and Nutrition Intervention for Possible Sarcopenia Among Older Adults in Primary Care

Recruiting

N/A

RoW

Experimental group

Kyunghee University Medical Center

Sarcopenia

12/24

MAeSTroⅡ-SDM, NCT06730893: Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer

Not yet recruiting

N/A

294

share decision aids

National Cancer Center, Korea, Seoul National University Hospital, Seoul National University Bundang Hospital, SMG-SNU Boramae Medical Center, Nowon Eulji Medical Center, Hanyang University

Thyroid Cancer, Papillary Thyroid Carcinoma

12/27

OPTION-STEMI, NCT04626882: Timing of FFR-guided PCI for Non-IRA in STEMI and MVD

Active, not recruiting

N/A

994

RoW

Staged in-hospital or Immediate complete revascularization

Chonnam National University Hospital

Myocardial Infarction, Acute, Multi-Vessel Coronary Artery Stenosis

02/25

12/29

NCT05276258: Cryoablation of Intercostal Nerves for Post-Operative Pain Management in Opioid-Tolerant Patients

Enrolling by invitation

N/A

cryoSPHERE Ablation, cryoSPHERE, Bupivacaine, liposomal bupivacaine, Exparel

The Methodist Hospital Research Institute

Pain, Pain, Postoperative

03/25

09/25

NCT05585411: PReventive Effect Of Left Bundle Branch Area Pacing Versus righT vEntricular paCing on All Cause deaTh, Heart Failure Progression, and Ventricular dysSYNChrony in Patients With Substantial Ventricular Pacing (PROTECT-SYNC): Multicenter Prospective Randomized Controlled Trial

Recruiting

N/A

450

RoW

Left bundle branch area pacing, Right ventricular pacing

Yonsei University

Bradyarrhythmia, Atrioventricular Block, Left Bundle Branch Area Pacing

11/26

PACE-SHOCK, NCT06078436: Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF

Recruiting

N/A

160

RoW

Pulmonary artery catheter, Swan-Ganz catheter

Min-Seok Kim

Heart Failure With Reduced Ejection Fraction, Cardiogenic Shock

09/27

03/28

RETHINK REFLUX, NCT04253392: Registry

Active, not recruiting

N/A

500

Europe, US, RoW

LINX Reflux Management System, LINX

Ethicon Endo-Surgery

Gastroesophageal Reflux

07/32

SOROCk, NCT04251052: A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Recruiting

N/A

2262

Canada, US, RoW

Bilateral Salpingectomy, Bilateral Salpingectomy with Oophorectomy, bilateral salpingo-oophorectomy, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Transvaginal Ultrasound, transvaginal sonography, TVS, TVU, Ultrasound Imaging, 2-Dimensional Grayscale Ultrasound Imaging, 2-Dimensional Ultrasound Imaging, 2D-US, Ultrasonography, Ultrasound, Ultrasound Test, Ultrasound, Medical, US

NRG Oncology, National Cancer Institute (NCI)

Ovarian Carcinoma

06/36

06/37

NCT04174157: Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Recruiting

N/A

700

Europe, Japan, US, RoW

Prospective observational registry, Zolgensma

Novartis Pharmaceuticals, United BioSource, LLC

Spinal Muscular Atrophy (SMA)

06/38

KOBOT, NCT02803970: KOrean Borderline Ovarian Tumor () Registry

Recruiting

N/A

3000

RoW

Kangbuk Samsung Hospital

Ovarian Neoplasms

12/40

NCT04999072: Carbohydrate Antigen 19-9 in Colorectal Cancer

Active, not recruiting

N/A

4972

RoW

Colectomy for colon cancer

Seoul National University Hospital

Colorectal Cancer

09/21

12/21

Sagong, Min

PROUD, NCT05666804: Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy

Recruiting

160

RoW

Brolucizumab 6mg, Beovu

Novartis Pharmaceuticals

Macular Polypoidal Choroidal Vasculopathy (PCV)

09/25

EB-203-201, NCT06487039: Trial to Evaluate the Safety and Efficacy of EB-203 in Patients With Neovascular Age-related Macular Degeneration

Recruiting

RoW

EB-203

EyebioKorea, Inc.

Neovascular Age-related Macular Degeneration (nAMD)

08/25

01/26

NCT06116916: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Recruiting

150

Japan, US, RoW

KHK4951, Aflibercept Injection

Kyowa Kirin Co., Ltd.

Diabetic Macular Edema (DME)

11/25

12/25

NCT06116890: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Recruiting

180

Japan, US, RoW

KHK4951, Aflibercept Injection

Kyowa Kirin Co., Ltd.

Neovascular Age-Related Macular Degeneration (nAMD)

11/25

12/25

PMC403-A01, NCT05953012: Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration

Recruiting

RoW

PMC-403, Monotherapy

PharmAbcine, C&R Research, Inc.

Neovascular Age-related Macular Degeneration

05/24

10/25

Do, Jun-Young

No trials found



	Diseases Companies Products Productz Mechanisms of Action Sites